MGMT inhibition in our model led to significant decrease in the multiple cell cycle regulatory targets tested suggesting that MGMT inhibition could be considered as an adjunct to distant inhibition of these multiple targets in the treatment of breast cancer. This evidence concerns the gene MGMT and breast cancer.